Providing clarity around ethical discussion: development of a neonatal intervention score.


Journal

Acta paediatrica (Oslo, Norway : 1992)
ISSN: 1651-2227
Titre abrégé: Acta Paediatr
Pays: Norway
ID NLM: 9205968

Informations de publication

Date de publication:
08 2019
Historique:
received: 09 11 2018
revised: 26 12 2018
accepted: 29 01 2019
pubmed: 2 2 2019
medline: 2 9 2020
entrez: 2 2 2019
Statut: ppublish

Résumé

To develop a Neonatal Intervention Score (NIS) to describe the clinical trajectory of a neonate throughout their neonatal intensive care unit (NICU) admission. The NIS was developed by modifying the Neonatal Therapeutic Intervention Scoring System (NTISS) to reflect illness severity, dependency on life-sustaining interventions and overall life trajectory on a longitudinal basis, rather than illness burden. Validity for longitudinal use within the NICU was tested by calculating the score for 99 preterm babies born less than 28 weeks at predetermined time points throughout their admission to tertiary level care at two institutions. A total of 1333 NISs were analysed, ranging from 0 to 32.5 (mean 9.77, SD 5.4). Internal consistency (Cronbach alpha) reached 0.8. NIS moderately correlated to both SNAPPE-II and SNAP-II (Spearman's rho = 0.47, p =< 0.001) within the first 24 hours. The NIS is a useful and reliable descriptive tool of relative illness severity and degree of medical interventions throughout a baby's admission. Integrating a longitudinal description of medical dependency of a patient may assist both clinical and ethical decision-making and empirical research by providing an objective account of a baby's clinical trajectory. Establishment of validity within individual institutions is required.

Identifiants

pubmed: 30707778
doi: 10.1111/apa.14732
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1453-1459

Subventions

Organisme : NHMRC
ID : 1150839
Pays : International
Organisme : Australian Government Research Training Program (RTP) Scholarship
Pays : International

Informations de copyright

©2019 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Auteurs

Trisha M Prentice (TM)

Newborn Research, Royal Women's Hospital, Melbourne, Vic., Australia.
Neonatal Medicine, Royal Children's Hospital, Melbourne, Vic., Australia.
Murdoch Children's Research Institute, Melbourne, Vic., Australia.
Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Vic., Australia.
Department of Paediatrics, University of Melbourne, Melbourne, Vic, Australia.

Annie Janvier (A)

Departement of Pediatrics, Division of Neonatology, Clinical Ethics Unit, Palliative Care Unit, Unité de Recherche en Éthique Clinique et Partenariat Famille, CHU Ste-Justine, Montreal, QC, Canada.
Departement of Pediatrics and Clinical Ethics, Universite de Montreal, Montreal, QC, Canada.

Lynn Gillam (L)

Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Vic., Australia.
Children's Bioethics Centre, Royal Children's Hospital, Melbourne, Vic., Australia.

Susan Donath (S)

Murdoch Children's Research Institute, Melbourne, Vic., Australia.
Department of Paediatrics, University of Melbourne, Melbourne, Vic, Australia.

Peter G Davis (PG)

Newborn Research, Royal Women's Hospital, Melbourne, Vic., Australia.
Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Vic., Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH